The easy and reliable method that measures all NAD metabolites has also convinced financiers. NADMED recently completed its first financing round of half a million euros, led by deep tech fund Voima Ventures. Other investors include individuals and members of the company’s executive management and board of directors.
Read more: https://voimaventures.com/nadmed-investment-news/